Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SITC 2021 | Should cancer patients undergoing immunotherapy get the COVID-19 vaccination?

Hannah E. Dzimitrowicz • 13 Nov 2021
SITC 2021
General

Hannah E. Dzimitrowicz, MD, Duke Cancer Center, Durham, NC, discusses the recommendation by several large oncology organisations, including the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO), for cancer patients undergoing immunotherapy treatment to get the COVID-19 vaccination. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.

More from Hannah E. Dzimitrowicz

Clinical activity of cabozantinib in patients with RCC with brain metastases
0:48
Clinical activity of cabozantinib in patients with RCC with brain metastases
Hannah E. Dzimitrowicz • 13 Nov 2021
COVID-19 vaccination in patients with RCC and melanoma treated with immune checkpoint inhibitors
2:13
COVID-19 vaccination in patients with RCC and melanoma treated with immune checkpoint inhibitors
Hannah E. Dzimitrowicz • 13 Nov 2021
Future research on COVID-19 vaccine for patients with cancer
0:28
Future research on COVID-19 vaccine for patients with cancer
Hannah E. Dzimitrowicz • 13 Nov 2021

Related Videos

PALEM: palliative arterial embolization for painful bone metastases
1:20
PALEM: palliative arterial embolization for painful bone metastases
Yasunori Arai • 26 Oct 2026
The benefits of arterial embolization for palliative pain management
1:21
The benefits of arterial embolization for palliative pain management
Yasunori Arai • 26 Oct 2026
Examining difficulties in patient selection for investigational immunotherapies
1:15
Examining difficulties in patient selection for investigational immunotherapies
Sebastian Kobold • 26 Oct 2026
Learning from early trials of cellular and vaccine-based immunotherapies
1:10
Learning from early trials of cellular and vaccine-based immunotherapies
Sebastian Kobold • 26 Oct 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals